vagrant - buyout would have happened, but I loaded up between $27-29. Now everyone will have to wait for me to get shaken out of my position before the buyout can be announced. So you still have time to get in, just buy the dip that shakes me out!
I picked up my first 100 shares of NK recently at $17. Figured I wasn't bottom fishing but thought it was at least getting close. nope. lol.. I still hold that 100 shares...
can't tell you what to do but will tell you what I'm doing. Holding, not buying. Hoping it goes down more on no news. If it keeps getting killed on no news, along with weakness in biotech index, I will buy more. If it takes off on a catalyst, I will probably buy more on momentum. The worst thing to do is load up here, as far as the odds of succeeding go. Yeah it might be the bottom but probably not - and it's cheap enough now that if it takes off on real news there will be time to chase it.
If you find you are already overexposed on this stock, I can't tell you what to do - but you should take it as a good lesson learned the hard way. It's money well spent if you learn not to bet too big on spec plays like this with no earnings. Spread that money around. If you do the research and pick a basket of good biotech specs you will have a much better chance of success. Betting big on one is essentially playing the lottery.
yeah, way too many novice investors bought that twtr run up. understandable... given what a popular brand it is and how integral it is in many lives. But I couldn't resist buying below $30 recently. The public is right they just had the timing wrong. Patience pays off...
yep. and market buys into it hook, line and sinker. I agree with your sentiment regarding putting your money where your mouth is. Otherwise... "you just talking jive baby."
who's your broker? do they have shares available? I want to call Ameritrade and yell at them. gonna take my biz elsewhere
to short. so annoying. tried to load up earlier. feels like everytime I find a no brainer sell play, shares are never available. little guys like me get scroood while the big boys get to manipulate stocks up and down with endless naked selling. Such a corrupt market.
Cramer's been recommending OPK from $5 or $6/share, since before the run to $19. People saying he's contrary indicator are full of it. I don't follow him either, I just ignore him and enjoy the sound effects if he's on the tv.
nope. trading normally lol. get a cup of coffee and take a bong hit, then get back to us
I appreciate yours as well, toe! and your input too. You make very good points. Question....
"in 2013 prescription drug expense was 9.3% of total U.S. health care expenditures...The big bucks, though, lie elsewhere and they are not sitting with the insurers."
aside from drugs, I'm assuming the big bucks lay with hospital procedures, inpatient and other infrastructure costs?
And of course the elephant in the room... longer lifespans. Which is a good thing! :)
Again I see room for cost cutting in some of those areas as well. There is no innovation in running a nursing home, etc. Yet the companies operating them are making a killing.
Love the discussion... thanks to everyone for commenting!
what I am saying is that, if you need to go after costs in the industry - why go after the companies that innovate? WHAT GROUNDBREAKING SCIENCE DO THE INSURANCE COMPANIES CREATE?
hear, hear!!! and the media never gives Rand a fair shake because the power structure is scared of him. He is the only candidate that is truly of the people.
if you were really looking out for the interests of the people you'd go after the insurance providers, not the companies that innovate for the benefit of mankind.
Why does she do it? Big bags of money from the health insurance lobby. Clinton gets to bang a populist drum while benefiting her masters.
Companies like CELG should be able to innovate without fear of price caps. The market will produce competition if you don't cut off the funding.
Why not focus on the insurance companies instead? What do they offer society? Insurance providers provide a service which should be compensated with a modest fee, not record profits.
shorts still smell desperate.
19:59:31 t 7.35 - 200 NSD
19:20:34 i 7.35 - 30
19:20:28 i 7.35 - 30
19:20:28 i 7.33 - 30
19:20:28 i 7.33 - 70
19:20:28 i 7.35 - 70
19:20:28 i 7.43 - 70
19:20:28 i 7.35 - 70
19:20:28 t 7.43 - 100
19:20:27 t 7.43 - 100
18:41:05 t 7.55 - 100
18:37:08 t 7.55 - 100
18:29:37 t 7.55 - 100
18:29:35 t 7.55 - 100
18:29:20 i 7.50 - 50
18:29:20 t 7.50 - 450
17:53:02 t 7.50 - 3500
a sign of desperation, but I'm not talking about Roche..... hehe
miami & greg are the same dude. no silver tongue on this one though!
miamigent1: "A Market Cap of 1.6B for a company with a niche product selling 10-15 machines a year.
Too funny. That's the last installment from Roche- then it's dilution as PACB has chronic negative cash flow. The only question is when is this walk-up going to dump."
greg.czar: "Pump dump scam, it's all over the penny stock pumping boards. This was expected news pretty. They sell 10-15 units in a year? They are losing money, only thing keeping them floating is roches milestone payments, ,and not make any money for the next few years. It will sink back like like all pump and dumps."
price is truth. at least on high volume it is. A stock with avg vol of 1m shares per day traded over 32m shares in two days, up well over 50%. Fundamentally, the explanation for the move doesn't take a genius either. Compare the PACB market cap to ILMN. PacBio doesn't need to steal much of ILMN's business to make a huge impact to their balance sheet.
Oct 2, 2015 - 10,962,000 - 6.13
Oct 1, 2015 - 21,719,100 - 5.45
Sep 30, 2015 - 1,150,300 - 3.66